Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - etoposide - injection - 100 mg/5 ml - etoposide 100 mg/5 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - etoposide, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - - small cell carcinoma of the lung. - acute monocytic and myelomonocytic leukaemia. - hodgkin's disease - non-hodgkin's lymphoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - etoposide, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - for the treatment of small cell lung cancer and testicular tumours, either as a single agent or in combination with other anticancer agents.

United States - English - NLM (National Library of Medicine)

teva parenteral medicines, inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - toposar (etoposide injection) is indicated in the management of the following neoplasms: toposar (etoposide injection) in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. toposar is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.

United States - English - NLM (National Library of Medicine)

e.r. squibb & sons, l.l.c. - etoposide phosphate (unii: 528xyj8l1n) (etoposide - unii:6plq3cp4p3) - etoposide 100 mg - etopophos is indicated, in combination with other chemotherapeutic drugs, for treatment of patients with refractory testicular tumors. etopophos is indicated, in combination with cisplatin, for first-line treatment of patients with small cell lung cancer. etopophos is contraindicated in patients with a history of a severe hypersensitivity reaction to etoposide products [see warnings and precautions (5.3)] . risk summary based on animal data and its mechanism of action, etopophos can cause fetal harm when administered to a pregnant woman. etoposide, the active moiety of etoposide phosphate is teratogenic in mice and rats (see data) . advise pregnant women of the potential hazard to a fetus. advise women of childbearing potential to avoid becoming pregnant. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. data animal data in rats, an intravenous etoposide dose of 0.4 m

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - etoposide, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - etoposide is primarily used for the treatment of testicular tumours, in combination with bleomycin and cisplatin, and in combination with cisplatin for small-cell carcinoma of the lung. it is also active against non-hodgkin?s lymphomas, acute nonlymphocytic leukemia, carcinoma of the breast and kaposi?s sarcoma associated with acquired immunodeficiency syndrome (aids).

Namibia - English - Namibia Medicines Regulatory Council

sandoz sa (pty) ltd - etoposide - solution for infusion - each 50ml solution contains etoposide 1000.0 mg

Namibia - English - Namibia Medicines Regulatory Council

sandoz sa (pty) ltd - etoposide - solution for infusion - each 20ml solution contains etoposide 400.0 mg

Namibia - English - Namibia Medicines Regulatory Council

sandoz sa (pty) ltd - etoposide - solution for infusion - each 2.5ml solution contains etoposide 50.0 mg

Namibia - English - Namibia Medicines Regulatory Council

sandoz sa (pty) ltd - etoposide - solution for infusion - each 10ml solution contains etoposide 200.0 mg